Monitoring compliance to topical therapy in children and young people with uveitis

Elspeth K Y Green1, Orlaith McGrath2, Laura Steeples2,3

  • 1Manchester Royal Eye Hospital, Oxford Road, Manchester, M13 9WL, UK. Elspeth.green@nhs.net.

Eye (London, England)
|November 6, 2023
PubMed

Insights

Pediatric uveitis patients show poor steroid eye drop compliance, with many missing over half their doses. This unreliability in adherence can lead to suboptimal disease control and vision complications.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Pharmacology

Background:

  • Pediatric uveitis is a rare but serious condition.
  • Steroid eye drops are the primary treatment, but poor adherence can cause vision loss.
  • Accurate compliance measurement is crucial for effective management.

Purpose of the Study:

  • To prospectively measure steroid eye drop compliance in children and young people (CYP) with uveitis.
  • To assess the reliability of self-reported compliance in this pediatric population.
  • To identify the extent of non-adherence and its potential impact on disease control.

Main Methods:

  • Recruited 50 CYP (aged 0-18) with uveitis using steroid drops.
  • Collected compliance data via questionnaires from CYP and their parents/guardians (PPR).
  • Subgroup analysis involved weighing steroid drop bottles before and after use to objectively measure consumption.

Main Results:

  • 33.3% of CYP and 9.7% of PPR reported frequent drop errors.
  • Many parents (40.6%) could not recall prescribed drop frequencies.
  • Bottle weighing revealed 75% of patients had insufficient weight reduction, with 25% using less than 50% of expected drops.

Conclusions:

  • Demonstrated significantly poor eye drop compliance among pediatric uveitis patients.
  • Self-reported compliance data was found to be unreliable.
  • A substantial proportion of patients miss critical medication doses, potentially leading to inadequate disease management and adverse outcomes.
Abstract